🇺🇸 FDA
Pipeline program

SK-PC-B70M

SMART_II_2006

Phase 2 small_molecule completed

Quick answer

SK-PC-B70M for Alzheimer's Disease is a Phase 2 program (small_molecule) at Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.) with 1 ClinicalTrials.gov record(s).

Program details

Company
Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Indication
Alzheimer's Disease
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials